$742 Million is the total value of Virtus ETF Advisers LLC's 159 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 22.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ETP | Buy | ENERGY TRANSFER PARTNERS LPunit ltd prt int | $93,549,000 | +10.2% | 5,114,749 | +22.8% | 12.61% | -0.5% |
WPZ | Buy | WILLIAMS PARTNERS L P NEW | $65,031,000 | +19.1% | 1,671,737 | +22.8% | 8.77% | +7.6% |
BPL | Buy | BUCKEYE PARTNERS L Punit ltd partn | $48,874,000 | +9.5% | 857,445 | +22.8% | 6.59% | -1.1% |
ET | Buy | ENERGY TRANSFER EQUITY L P | $45,178,000 | +6.7% | 2,599,426 | +10.3% | 6.09% | -3.6% |
EPD | Buy | ENTERPRISE PRODS PARTNERS L | $40,195,000 | +21.4% | 1,541,809 | +26.1% | 5.42% | +9.7% |
MPLX | Buy | MPLX LP | $35,769,000 | +21.3% | 1,021,677 | +15.7% | 4.82% | +9.5% |
EEP | Buy | ENBRIDGE ENERGY PARTNERS L P | $34,157,000 | +22.7% | 2,137,474 | +22.8% | 4.60% | +10.8% |
ENLK | Buy | ENLINK MIDSTREAM PARTNERS LP | $29,087,000 | +21.4% | 1,735,472 | +22.8% | 3.92% | +9.6% |
MPC | Buy | MARATHON PETE CORP | $28,525,000 | +575.9% | 508,655 | +530.8% | 3.84% | +510.3% |
ANDX | New | ANDEAVOR LOGISTICS LP | $27,887,000 | – | 557,073 | +100.0% | 3.76% | – |
EQM | Buy | EQT MIDSTREAM PARTNERS LPunit ltd partn | $24,261,000 | +20.8% | 323,612 | +20.3% | 3.27% | +9.1% |
OKE | Buy | ONEOK INC NEW | $16,643,000 | +15.1% | 300,355 | +8.3% | 2.24% | +3.9% |
PSXP | Buy | PHILLIPS 66 PARTNERS LP | $14,955,000 | +30.6% | 284,541 | +22.8% | 2.02% | +18.0% |
GEL | Buy | GENESIS ENERGY L Punit ltd partn | $13,941,000 | +2.0% | 529,074 | +22.8% | 1.88% | -7.9% |
WES | Buy | WESTERN GAS PARTNERS LP | $12,649,000 | +12.6% | 246,660 | +22.8% | 1.70% | +1.7% |
KMI | Buy | KINDER MORGAN INC DEL | $10,851,000 | +32.7% | 565,747 | +32.6% | 1.46% | +19.9% |
NS | Buy | NUSTAR ENERGY LP | $10,555,000 | +6.9% | 260,030 | +22.8% | 1.42% | -3.5% |
TEP | Buy | TALLGRASS ENERGY PARTNERS LP | $9,775,000 | +17.4% | 204,111 | +22.8% | 1.32% | +6.0% |
WMB | Buy | WILLIAMS COS INC DEL | $9,512,000 | +4.4% | 316,952 | +5.3% | 1.28% | -5.7% |
DCP | Buy | DCP MIDSTREAM PARTNERS LP | $8,082,000 | +25.8% | 233,301 | +22.8% | 1.09% | +13.6% |
AM | Buy | ANTERO MIDSTREAM PARTNERS LPunt ltd partn | $8,021,000 | +26.4% | 254,406 | +33.1% | 1.08% | +14.1% |
NGL | Buy | NGL ENERGY PARTNERS LP | $7,132,000 | +1.3% | 617,529 | +22.8% | 0.96% | -8.6% |
TCP | Buy | TC PIPELINES LP | $6,463,000 | +16.8% | 123,526 | +22.8% | 0.87% | +5.4% |
ENLC | Buy | ENLINK MIDSTREAM LLC | $6,285,000 | +20.4% | 364,345 | +22.8% | 0.85% | +8.7% |
WGP | Buy | WESTERN GAS EQUITY PARTNERS | $5,762,000 | +17.6% | 139,927 | +22.9% | 0.78% | +6.3% |
TRGP | Buy | TARGA RES CORP | $4,287,000 | +25.8% | 90,638 | +20.3% | 0.58% | +13.6% |
VPU | Buy | VANGUARD WORLD FDSutilities etf | $3,418,000 | +29.3% | 29,270 | +26.5% | 0.46% | +16.7% |
VDE | Buy | VANGUARD WORLD FDSenergy etf | $1,717,000 | +52.8% | 18,349 | +44.5% | 0.23% | +37.5% |
WELLPRI | Buy | WELLTOWER INC6.50% pfd prepet | $1,638,000 | +20.6% | 25,828 | +26.0% | 0.22% | +8.9% |
ENB | Buy | ENBRIDGE INC | $1,457,000 | +29.1% | 34,816 | +22.8% | 0.20% | +16.0% |
CQP | Buy | CHENIERE ENERGY PARTNERS LP | $1,255,000 | +9.3% | 43,552 | +22.9% | 0.17% | -1.2% |
FAS | New | DIREXION SHS ETF TRdly fin bull new | $1,148,000 | – | 20,503 | +100.0% | 0.16% | – |
SEP | Buy | SPECTRA ENERGY PARTNERS LP | $993,000 | +27.1% | 22,367 | +22.9% | 0.13% | +14.5% |
GDX | New | VANECK VECTORS ETF TRgold miners etf | $853,000 | – | 37,167 | +100.0% | 0.12% | – |
BGNE | Buy | BEIGENE LTDsponsored adr | $839,000 | +146.8% | 8,113 | +7.4% | 0.11% | +121.6% |
SGMO | Buy | SANGAMO BIOSCIENCES INC | $660,000 | +87.5% | 43,982 | +10.1% | 0.09% | +67.9% |
INSM | Buy | INSMED INC | $649,000 | +100.3% | 20,798 | +10.1% | 0.09% | +81.2% |
JUNO | Buy | JUNO THERAPEUTICS INC | $640,000 | +65.4% | 14,261 | +10.1% | 0.09% | +48.3% |
VNQ | Buy | VANGUARD INDEX FDSreit etf | $641,000 | +34.4% | 7,711 | +34.7% | 0.09% | +21.1% |
TLT | New | ISHARES TR20 yr tr bd etf | $610,000 | – | 4,889 | +100.0% | 0.08% | – |
FGEN | Buy | FIBROGEN INC | $607,000 | +83.4% | 11,278 | +10.1% | 0.08% | +67.3% |
IMMU | Buy | IMMUNOMEDICS INC | $598,000 | +74.3% | 42,784 | +10.1% | 0.08% | +58.8% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $592,000 | +51.4% | 8,495 | +10.1% | 0.08% | +37.9% |
FOLD | Buy | AMICUS THERAPEUTICS INC | $576,000 | +64.6% | 38,223 | +10.1% | 0.08% | +50.0% |
RGNX | Buy | REGENXBIO INC | $569,000 | +83.5% | 17,271 | +10.1% | 0.08% | +67.4% |
IMGN | Buy | IMMUNOGEN INC | $536,000 | +18.6% | 70,035 | +10.1% | 0.07% | +7.5% |
ONCE | Buy | SPARK THERAPEUTICS INC | $519,000 | +56.3% | 5,818 | +4.8% | 0.07% | +40.0% |
MCRB | Buy | SERES THERAPEUTICS INC | $518,000 | +56.5% | 32,276 | +10.1% | 0.07% | +42.9% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $518,000 | +61.9% | 4,411 | +10.1% | 0.07% | +45.8% |
ARRY | Buy | ARRAY BIOPHARMA INC | $520,000 | +62.0% | 42,236 | +10.1% | 0.07% | +45.8% |
EPZM | Buy | EPIZYME INC | $509,000 | +39.1% | 26,709 | +10.1% | 0.07% | +25.5% |
SHLX | Buy | SHELL MIDSTREAM PARTNERS L Punit ltd int | $501,000 | +12.6% | 18,010 | +22.7% | 0.07% | +3.0% |
PBYI | Buy | PUMA BIOTECHNOLOGY INC | $497,000 | +51.1% | 4,147 | +10.1% | 0.07% | +36.7% |
ITCI | Buy | INTRA CELLULAR THERAPIES INC | $483,000 | +40.0% | 30,600 | +10.1% | 0.06% | +27.5% |
PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $483,000 | +5.9% | 8,940 | +10.1% | 0.06% | -4.4% |
RXDX | Buy | IGNYTA INC | $474,000 | +31.3% | 38,356 | +10.1% | 0.06% | +18.5% |
ESPR | Buy | ESPERION THERAPEUTICS INC NE | $464,000 | +19.3% | 9,250 | +10.1% | 0.06% | +8.6% |
FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $449,000 | +49.7% | 10,966 | +10.1% | 0.06% | +35.6% |
AKBA | Buy | AKEBIA THERAPEUTICS INC | $453,000 | +50.5% | 23,019 | +10.1% | 0.06% | +35.6% |
AIMT | Buy | AIMMUNE THERAPEUTICS INC | $444,000 | +32.9% | 17,898 | +10.1% | 0.06% | +20.0% |
AVXS | Buy | AVEXIS INC | $448,000 | +29.5% | 4,636 | +10.1% | 0.06% | +15.4% |
CTMX | Buy | CYTOMX THERAPEUTICS INC | $437,000 | +28.9% | 24,077 | +10.1% | 0.06% | +15.7% |
AGIO | Buy | AGIOS PHARMACEUTICALS INC | $430,000 | +42.9% | 6,435 | +10.1% | 0.06% | +28.9% |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $423,000 | +16.2% | 54,523 | +10.1% | 0.06% | +5.6% |
LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $412,000 | +28.8% | 11,845 | +10.1% | 0.06% | +16.7% |
AGEN | Buy | AGENUS INC | $417,000 | +24.1% | 94,517 | +10.1% | 0.06% | +12.0% |
XLRN | Buy | ACCELERON PHARMA INC | $410,000 | +35.3% | 10,977 | +10.1% | 0.06% | +22.2% |
GLYC | Buy | GLYCOMIMETICS INC | $405,000 | +37.8% | 28,961 | +10.1% | 0.06% | +25.0% |
LOXO | Buy | LOXO ONCOLOGY INC | $407,000 | +26.8% | 4,413 | +10.1% | 0.06% | +14.6% |
CRBP | Buy | CORBUS PHARMACEUTICALS HLDGS | $400,000 | +25.0% | 55,909 | +10.1% | 0.05% | +12.5% |
BLUE | Buy | BLUEBIRD BIO INC | $404,000 | +43.8% | 2,945 | +10.1% | 0.05% | +28.6% |
RETA | Buy | REATA PHARMACEUTICALS INCcl a | $402,000 | +8.1% | 12,925 | +10.1% | 0.05% | -3.6% |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $400,000 | +27.4% | 139,774 | +10.1% | 0.05% | +14.9% |
KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $393,000 | +33.7% | 35,776 | +10.1% | 0.05% | +20.5% |
PTCT | Buy | PTC THERAPEUTICS INC | $392,000 | +19.9% | 19,612 | +10.1% | 0.05% | +8.2% |
PRTA | Buy | PROTHENA CORP PLC | $392,000 | +32.0% | 6,048 | +10.1% | 0.05% | +20.5% |
PRTK | Buy | PARATEK PHARMACEUTICALS INC | $370,000 | +14.9% | 14,726 | +10.1% | 0.05% | +4.2% |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $368,000 | +25.2% | 11,845 | +10.1% | 0.05% | +13.6% |
XNCR | Buy | XENCOR INC | $364,000 | +19.3% | 15,881 | +10.1% | 0.05% | +6.5% |
ZIOP | Buy | ZIOPHARM ONCOLOGY INC | $362,000 | +8.7% | 59,009 | +10.1% | 0.05% | -2.0% |
CALA | Buy | CALITHERA BIOSCIENCES INC | $367,000 | +16.5% | 23,312 | +10.1% | 0.05% | +4.3% |
ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $348,000 | +7.7% | 77,433 | +10.1% | 0.05% | -2.1% |
NVAX | Buy | NOVAVAX INC | $351,000 | +9.0% | 308,286 | +10.1% | 0.05% | -2.1% |
TGTX | Buy | TG THERAPEUTICS INC | $349,000 | +29.7% | 29,453 | +10.1% | 0.05% | +17.5% |
CYTK | Buy | CYTOKINETICS INC | $339,000 | +31.9% | 23,395 | +10.1% | 0.05% | +21.1% |
AQXP | Buy | AQUINOX PHARMACEUTICALS INC | $339,000 | +11.1% | 23,869 | +10.1% | 0.05% | 0.0% |
MGNX | Buy | MACROGENICS INC | $341,000 | +16.4% | 18,449 | +10.1% | 0.05% | +4.5% |
ADRO | Buy | ADURO BIOTECH INC | $327,000 | +2.8% | 30,685 | +10.1% | 0.04% | -6.4% |
JNCE | Buy | JOUNCE THERAPEUTICS INC | $316,000 | +22.0% | 20,298 | +10.1% | 0.04% | +10.3% |
RIGL | Buy | RIGEL PHARMACEUTICALS INC | $321,000 | +2.6% | 126,385 | +10.1% | 0.04% | -8.5% |
TTPH | Buy | TETRAPHASE PHARMACEUTICALS I | $308,000 | +5.5% | 45,001 | +10.1% | 0.04% | -4.5% |
BCRX | Buy | BIOCRYST PHARMACEUTICALS | $298,000 | +3.8% | 56,873 | +10.1% | 0.04% | -7.0% |
RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $285,000 | -5.6% | 5,343 | +10.1% | 0.04% | -15.6% |
GERN | Buy | GERON CORP | $273,000 | -13.6% | 125,425 | +10.1% | 0.04% | -21.3% |
UPW | Buy | PROSHARES TR | $277,000 | +7.8% | 5,800 | +1.5% | 0.04% | -2.6% |
SAGE | Buy | SAGE THERAPEUTICS INC | $264,000 | -13.7% | 4,234 | +10.1% | 0.04% | -21.7% |
INO | Buy | INOVIO PHARMACEUTICALS INC | $261,000 | -11.2% | 41,233 | +10.1% | 0.04% | -20.5% |
CARA | Buy | CARA THERAPEUTICS INC | $259,000 | -1.9% | 18,915 | +10.1% | 0.04% | -10.3% |
NERV | Buy | MINERVA NEUROSCIENCES INC | $260,000 | -5.5% | 34,183 | +10.1% | 0.04% | -14.6% |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $239,000 | -17.9% | 19,472 | +10.1% | 0.03% | -25.6% |
New | UNITED STATES OIL FUND LPcall | $175,000 | – | 87,212 | +100.0% | 0.02% | – | |
New | SPDR S&P 500 ETF TRcall | $111,000 | – | 1,800 | +100.0% | 0.02% | – | |
DM | New | DOMINION MIDSTREAM PARTNERS | $102,000 | – | 3,189 | +100.0% | 0.01% | – |
AXGT | Buy | AXOVANT SCIENCES LTD | $97,000 | -67.4% | 14,151 | +10.1% | 0.01% | -70.5% |
New | UNITED STATES NATL GAS FUNDcall | $82,000 | – | 41,012 | +100.0% | 0.01% | – | |
VSAR | Buy | VERSARTIS INC | $49,000 | -84.5% | 19,991 | +10.1% | 0.01% | -85.1% |
New | JPMORGAN CHASE & COcall | $45,000 | – | 9,000 | +100.0% | 0.01% | – | |
New | ENERGY TRANSFER EQUITY L Pput | $32,000 | – | 7,942 | +100.0% | 0.00% | – | |
New | ISHARES TRcall | $25,000 | – | 12,432 | +100.0% | 0.00% | – | |
New | ONEOK INC NEWput | $20,000 | – | 2,000 | +100.0% | 0.00% | – | |
New | KINDER MORGAN INC DELcall | $16,000 | – | 4,000 | +100.0% | 0.00% | – | |
New | ISHARES TRput | $7,000 | – | 1,400 | +100.0% | 0.00% | – | |
New | WILLIAMS COS INC DELput | $4,000 | – | 800 | +100.0% | 0.00% | – | |
New | MARATHON PETE CORPput | $9,000 | – | 1,607 | +100.0% | 0.00% | – | |
New | UNITED STATES NATL GAS FUNDput | $4,000 | – | 744 | +100.0% | 0.00% | – | |
New | ENTERPRISE PRODS PARTNERS Lcall | $2,000 | – | 300 | +100.0% | 0.00% | – | |
New | ENERGY TRANSFER PARTNERS LPcall | $1,000 | – | 100 | +100.0% | 0.00% | – | |
New | ONEOK INC NEWcall | $1,000 | – | 201 | +100.0% | 0.00% | – | |
New | PLAINS ALL AMERN PIPELINE Lcall | $2,000 | – | 450 | +100.0% | 0.00% | – | |
New | MARATHON PETE CORPcall | $3,000 | – | 2,885 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
INCYTE CORP | 31 | Q3 2023 | 2.1% |
ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
EXELIXIS INC | 31 | Q3 2023 | 1.8% |
VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-15 |
13F-HR | 2023-11-07 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.